Literature DB >> 2947156

[Ventricular staphylococcal infections. Treatment with vancomycin by continuous venous infusion].

A Barois, B Estournet, J B Moranne, J Piliot, C Chabenat, J Bataille.   

Abstract

Thirteen cases of meningeal and/or ventricular infection and 1 case of septicaemia, all caused by staphylococci, were treated with continuous intravenous infusions of vancomycin. Repeated measurements of vancomycin plasma and CSF levels by microbiological assay or by high performance liquid chromatography showed that the antibiotic entered the CSF after 48 hours of treatment and that its concentrations in CSF remained stable at 1 to 4 micrograms/ml (mean: 2 micrograms/ml) throughout the 3 weeks' treatment period. After treatment was discontinued, vancomycin became undetectable in CSF within less than 24 hours. All the children were cured.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947156

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  6 in total

1.  Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.

Authors:  F Pawlotsky; A Thomas; M F Kergueris; T Debillon; J C Roze
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

2.  Comparison of Continuous and Intermittent IV Infusion of Vancomycin: Systematic Review.

Authors:  Sally S K Man; Roxane R Carr; Mary H H Ensom
Journal:  Can J Hosp Pharm       Date:  2010-09

3.  Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit.

Authors:  J Albanèse; M Léone; B Bruguerolle; M L Ayem; B Lacarelle; C Martin
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.

Authors:  M Wysocki; F Delatour; F Faurisson; A Rauss; Y Pean; B Misset; F Thomas; J F Timsit; T Similowski; H Mentec; L Mier; D Dreyfuss
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

5.  Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.

Authors:  J K James; S M Palmer; D P Levine; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.

Authors:  Baudouin Byl; Frédérique Jacobs; Pierre Wallemacq; Camelia Rossi; Philippe de Francquen; Matteo Cappello; Teresinha Leal; Jean-Pierre Thys
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.